Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study.
Campochiaro PA, Avery R, Brown DM, Heier JS, Ho AC, Huddleston SM, Jaffe GJ, Khanani AM, Pakola S, Pieramici DJ, Wykoff CC, Van Everen S.
Lancet. 2024 Apr 20;403(10436):1563-1573. doi: 10.1016/S0140-6736(24)00310-6. Epub 2024 Mar 27.
PMID:38554726
Peripheral Inflammatory Yellow Exudative Retinal Coats-Like Vitreoretinopathy Misdiagnosed as Acute Retinal Necrosis in a Retinitis Pigmentosa Patient after Cataract Surgery.
Tran L, Papasavvas I, Fleischhauer J, Herbort CP Jr.
Case Rep Ophthalmol. 2021 Jun 18;12(2):562-568. doi: 10.1159/000516312. eCollection 2021 May-Aug.
PMID:34248592
[Characteristics of inflammatory response in patients after senile cataract surgery].
Moskalets OV, Rusanova EV, Koval'kova DA.
Adv Gerontol. 2016;29(5):751-755.
PMID:28556644
Intravitreal triamcinolone acetonide: a change in a paradigm.
Jonas JB.
Ophthalmic Res. 2006;38(4):218-45. doi: 10.1159/000093796. Epub 2006 Jun 6.
PMID:16763379
Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.